Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Nutr Health Aging ; 20(6): 665-70, 2016.
Article in English | MEDLINE | ID: mdl-27273358

ABSTRACT

BACKGROUND: Proton-pump inhibitors (PPI) are extensively prescribed in older patients. However, little information is available on factors associated to PPI prescribing patterns among older patients discharged from hospital. OBJECTIVE: To evaluate the appropriateness and clinical correlates of PPI prescription at discharge in a population of 1081 older patients discharged from acute care Italian hospitals. DESIGN: We used data from the CRiteria to Assess Appropriate Medication Use among Elderly Complex Patients (CRIME) study, a multicenter observational study. The appropriateness of PPI prescriptions was defined according to the Italian Medicines Agency (AIFA) rules. Correlates of overprescribing (i.e prescribing without recognized AIFA indications) and underprescribing (i.e. not prescribing despite the presence of recognized AIFA indications) were investigated by logistic regression analysis. RESULTS: Overprescribing was observed in 30% of patients receiving PPIs at discharge. Underprescribing was observed in 11% of patients not receiving PPIs at discharge. Overprescribing of PPIs at discharge was negatively associated with age (OR=0.88, 95%CI=0.85-0.91), depression (OR=0.58, 95%CI=0.35-0.96), use of aspirin (OR=0.03, 95%CI=0.02-0.06) and systemic corticosteroids (OR=0.02, 95%CI=0.01-0.04). The negative association with number of medications (OR=0.95, 95%CI=0.88-1.03) and overall comorbidities (OR=0.92, 95%CI=0.83-1.02) was nearly significant. Conversely, older age (OR=1.09, 95%CI=1.04-1.14), use of aspirin (OR=24.0, 95%CI=11.5-49.8) and systemic corticosteroids (OR=19.3, 95%CI=11.5-49.8) and overall comorbidities (OR=1.22, 95%CI=1.04-1.42) were independent correlates of underprescribing. CONCLUSION: Overprescribing of PPIs is more frequent in younger patients with lower burden of depression, whilst underprescribing is characterized by older age and greater burden of comorbidity and polypharmacy. Hospitalization should be considered as a clue to identify inappropriate use of PPIs and improve appropriateness of prescribing.


Subject(s)
Inappropriate Prescribing/adverse effects , Proton Pump Inhibitors/therapeutic use , Aged, 80 and over , Female , Hospitalization , Humans , Male , Patient Discharge , Polypharmacy , Proton Pump Inhibitors/administration & dosage
2.
Science ; 294(5541): 361-4, 2001 Oct 12.
Article in English | MEDLINE | ID: mdl-11520949

ABSTRACT

Small molecules that affect specific protein functions can be valuable tools for dissecting complex cellular processes. Peptidoglycan synthesis and degradation is a process in bacteria that involves multiple enzymes under strict temporal and spatial regulation. We used a set of small molecules that inhibit the transglycosylation step of peptidoglycan synthesis to discover genes that help to regulate this process. We identified a gene responsible for the susceptibility of Escherichia coli cells to killing by glycolipid derivatives of vancomycin, thus establishing a genetic basis for activity differences between these compounds and vancomycin.


Subject(s)
Anti-Bacterial Agents/pharmacology , Escherichia coli/drug effects , Genes, Bacterial , Peptidoglycan/biosynthesis , Vancomycin/analogs & derivatives , Vancomycin/pharmacology , Anti-Bacterial Agents/chemistry , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Drug Resistance, Microbial , Drug Resistance, Multiple , Enzyme Inhibitors/pharmacology , Escherichia coli/genetics , Escherichia coli/growth & development , Genetic Complementation Test , Glycosylation , Hexosyltransferases/antagonists & inhibitors , Lipoproteins/genetics , Lipoproteins/metabolism , Microbial Sensitivity Tests , Mutation , N-Acetylmuramoyl-L-alanine Amidase/metabolism , Oligosaccharides/chemistry , Oligosaccharides/pharmacology , Peptidoglycan Glycosyltransferase , Phenotype , Vancomycin/chemistry , Vancomycin Resistance/genetics
3.
MAGMA ; 9(1-2): 5-15, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10555168

ABSTRACT

The aims of this study are to determine visualization of normal phonation structures with the use of MR fast sequences and anatomical reference indices which can be used in evaluating upper resonator pathologies. A total of 12 normal subjects were studied, a 1 T system, a volumetric receiving head and neck coil and FLASH sequences for one sagittal and two coronal scans. Each subject was instructed to take a deep breath and then to produce the vowel sounds for the entire duration of the scan. The movement of the following anatomical structures were considered: lips, tongue, soft palate, pharynx and epiglottis. For each subject sagittal scans were used to measure the minimal palate tongue distance (p-t), the minimal anterio-posterior diameter of the mesopharynx (mp), and the epiglottis excursion angle (ep) with respect to the plane determined by the false vocal cords. Our results were compared with a diagrammed representation of tongue movements (vocal trapezium). This study underlines the validity of MR imaging techniques in the study of the phono-articulatory tract, because MR provided good detail of the phono-articulatory structures enabling an overall functional evaluation. MR would appear useful in evaluating defects in the velum and palate, in staging of oropharyngeal neoplasms and in surgical reconstructions of the tongue.


Subject(s)
Magnetic Resonance Imaging/methods , Speech/physiology , Adult , Epiglottis/anatomy & histology , Epiglottis/physiology , Evaluation Studies as Topic , Female , Humans , Lip/anatomy & histology , Lip/physiology , Male , Palate, Soft/anatomy & histology , Palate, Soft/physiology , Pharynx/anatomy & histology , Pharynx/physiology , Phonetics , Tongue/anatomy & histology , Tongue/physiology , Vocal Cords/anatomy & histology , Vocal Cords/physiology
4.
Genomics ; 9(1): 104-12, 1991 Jan.
Article in English | MEDLINE | ID: mdl-1672283

ABSTRACT

Huntington disease (HD) is caused by a genetic defect distal to the anonymous DNA marker D4S10 in the terminal cytogenetic subband of the short arm of chromosome 4 (4p16.3). The effort to identify new markers linked to HD has concentrated on the use of somatic cell hybrid panels that split 4p16.3 into proximal and distal portions. Here we report two new polymorphic markers in the proximal portion of 4p16.3, distal to D4S10. Both loci, D4S126 and D4S127, are defined by cosmids isolated from a library enriched for sequences in the 4pter-4p15.1 region. Physical mapping by pulsed-field gel electrophoresis places D4S126 200 kb telomeric to D4S10, while D4S127 is located near the more distal marker D4S95. Typing of a reference pedigree for D4S126 and D4S127 and for the recently described VNTR marker D4S125 has firmly placed these loci on the existing linkage map of 4p16.3. This genetic analysis has revealed that the region immediately distal to D4S10 shows a dramatically higher rate of recombination than would be expected based on its physical size. D4S10-D4S126-D4S125 span 3.5 cM, but only 300-400 kb of DNA. Consequently, this small region accounts for most of the reported genetic distance between D4S10 and HD. By contrast, it was not possible to connect D4S127 to D4S125 by physical mapping, although they are only 0.3 cM apart. A more detailed analysis of recombination sites within the immediate vicinity of D4S10 could potentially reveal the molecular basis for this phenomenon; however, it is clear that the rate of recombination is not continuously increased with progress toward the telomere of 4p.


Subject(s)
Chromosomes, Human, Pair 4 , Genetic Linkage , Genetic Markers , Huntington Disease/genetics , Recombination, Genetic , Animals , Cell Line , Chromosome Mapping , Cosmids , Cricetinae , Humans , Hybrid Cells , Polymorphism, Restriction Fragment Length
5.
J Med Genet ; 24(9): 529-30, 1987 Sep.
Article in English | MEDLINE | ID: mdl-3118032

ABSTRACT

We have used DNA linkage analysis in 11 families with Von Recklinghausen neurofibromatosis (VRNF) in order to search for the chromosomal localisation of the defective gene causing this serious neurological disorder. Three groups of polymorphic DNA markers were used: (1) markers for chromosome 22, because of possible allelic genetic heterogeneity between VRNF and bilateral acoustic neurofibromatosis; (2) markers near the centromere of chromosome 4, since there was preliminary evidence for linkage between the VRNF gene and Gc; and (3) oncogenes and growth factors as possible candidate genes for VRNF. Our data exclude close linkage between any of these markers and the gene for VRNF.


Subject(s)
DNA/genetics , Neurofibromatosis 1/genetics , Genetic Linkage , Genetic Markers , Humans , Polymorphism, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...